Neuren Pharmaceuticals (STU:NK9) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Neuren Pharmaceuticals Days Payable?

Neuren Pharmaceuticals's average Accounts Payable for the six months ended in Jun. 2024 was €2.3 Mil. Neuren Pharmaceuticals's Cost of Goods Sold for the six months ended in Jun. 2024 was €0.0 Mil.

The historical rank and industry rank for Neuren Pharmaceuticals's Days Payable or its related term are showing as below:

STU:NK9's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 127.14
* Ranked among companies with meaningful Days Payable only.

Neuren Pharmaceuticals's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Neuren Pharmaceuticals Days Payable Historical Data

The historical data trend for Neuren Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuren Pharmaceuticals Days Payable Chart

Neuren Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Neuren Pharmaceuticals Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Neuren Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Neuren Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuren Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neuren Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Neuren Pharmaceuticals's Days Payable falls into.

Neuren Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Neuren Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.166	+	0.422)	/	2 )	/	0	*	365
=	0.294					/	0	*	365
=	N/A

Neuren Pharmaceuticals's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (0.422	+	4.158)	/	2 )	/	0	*	365 / 2
=	2.29					/	0	*	365 / 2
=	N/A

Neuren Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Neuren Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuren Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuren Pharmaceuticals Ltd (STU:NK9) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

NURPF:USA NEU:Australia

Address

697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.neurenpharma.com

Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.

Neuren Pharmaceuticals Headlines

No Headlines